Technology assessment in UK unable to keep up with pace of innovation
This article was originally published in Clinica
Health professionals in the UK are concerned that the body charged with evaluating new medical technology for the National Health Service cannot keep up with the rapid pace of innovation.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.